463 related articles for article (PubMed ID: 33147621)
1. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
2. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
3. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
[TBL] [Abstract][Full Text] [Related]
4. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
5. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
[TBL] [Abstract][Full Text] [Related]
6. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
Dirkx MF; Zach H; van Nuland A; Bloem BR; Toni I; Helmich RC
Brain; 2019 Oct; 142(10):3144-3157. PubMed ID: 31509182
[TBL] [Abstract][Full Text] [Related]
7. The patient's perspective: The effect of levodopa on Parkinson symptoms.
Zach H; Dirkx M; Pasman JW; Bloem BR; Helmich RC
Parkinsonism Relat Disord; 2017 Feb; 35():48-54. PubMed ID: 27919585
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Zach H; Dirkx MF; Roth D; Pasman JW; Bloem BR; Helmich RC
Neurology; 2020 Sep; 95(11):e1461-e1470. PubMed ID: 32651292
[TBL] [Abstract][Full Text] [Related]
9. Re-emergent tremor in Parkinson's disease: the effect of dopaminergic treatment.
Belvisi D; Conte A; Cutrona C; Costanzo M; Ferrazzano G; Fabbrini G; Berardelli A
Eur J Neurol; 2018 Jun; 25(6):799-804. PubMed ID: 29512863
[TBL] [Abstract][Full Text] [Related]
10. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
11. Pathologic gambling in patients with Parkinson's disease.
Gschwandtner U; Aston J; Renaud S; Fuhr P
Clin Neuropharmacol; 2001; 24(3):170-2. PubMed ID: 11391129
[TBL] [Abstract][Full Text] [Related]
12. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
13. Tremor and dopamine agonists.
Elble RJ
Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
[TBL] [Abstract][Full Text] [Related]
14. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Treatment of Parkinson Disease: A Review.
Armstrong MJ; Okun MS
JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
[TBL] [Abstract][Full Text] [Related]
16. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
17. Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease.
Cools R; Tichelaar JG; Helmich RCG; Bloem BR; Esselink RAJ; Smulders K; Timmer MHM
Prog Brain Res; 2022; 269(1):309-343. PubMed ID: 35248200
[TBL] [Abstract][Full Text] [Related]
18. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.
Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M
J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892
[TBL] [Abstract][Full Text] [Related]
19. The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication.
Castiello U; Bennett KM; Bonfiglioli C; Peppard RF
Neuropsychologia; 2000; 38(1):46-59. PubMed ID: 10617291
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
